[CYCC] QoQ Quarter Result on 31-Mar-2011 [#Q1]

Stock
[CYCC] Cyclacel Pharmaceuticals, Inc.
Announcement Date
16-May-2011
Financial Year
2011
Quarter
31-Mar-2011 [#Q1]
Profit Trend
QoQ- -44.64%
YoY- 10.23%
Quarter Report
CYCC's Result
CYCC's Financial Summary
View:
Show?
Quarter Result
31/12/11 30/09/11 30/06/11 31/03/11 31/12/10 30/09/10 30/06/10 CAGR
Revenue 175 164 168 192 138 159 119 29.22%
PBT -3,780 -3,571 -3,678 -4,779 -3,323 -3,950 -4,163 -6.21%
Tax -122 -126 -126 -191 -151 -143 -230 -34.39%
NP -3,658 -3,445 -3,552 -4,588 -3,172 -3,807 -3,933 -4.70%
Tax Rate - - - - - - - -
Total Cost 3,833 3,609 3,720 4,780 3,310 3,966 4,052 -3.62%
Ratio Analysis
31/12/11 30/09/11 30/06/11 31/03/11 31/12/10 30/09/10 30/06/10 CAGR
NP Margin -2,090.29 -2,100.61 -2,114.29 -2,389.58 -2,298.55 -2,394.34 -3,305.04 -26.25%
Per Share
31/12/11 30/09/11 30/06/11 31/03/11 31/12/10 30/09/10 30/06/10 CAGR
EPS -113.25 -107.75 -128.11 -165.51 -115.84 -172.72 -180.70 -26.70%
EPS Diluted -112.22 -107.75 -128.11 -165.51 -114.43 -172.72 -180.70 -27.14%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.